Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychopharmacology | 11 | 2004 | 26 | 2.390 |
Why?
|
Psychotropic Drugs | 5 | 2003 | 75 | 0.750 |
Why?
|
Specialization | 2 | 2010 | 65 | 0.600 |
Why?
|
Psychiatry | 3 | 2006 | 78 | 0.550 |
Why?
|
Drug Industry | 3 | 2004 | 54 | 0.530 |
Why?
|
Pharmaceutical Preparations | 3 | 2003 | 92 | 0.480 |
Why?
|
Antidepressive Agents | 2 | 2004 | 106 | 0.470 |
Why?
|
Education, Medical | 3 | 2006 | 231 | 0.330 |
Why?
|
Education, Medical, Undergraduate | 1 | 2010 | 160 | 0.320 |
Why?
|
Personal Satisfaction | 1 | 2006 | 62 | 0.280 |
Why?
|
Attitude | 1 | 2006 | 126 | 0.270 |
Why?
|
Students, Medical | 1 | 2010 | 384 | 0.260 |
Why?
|
Persuasive Communication | 1 | 2004 | 7 | 0.250 |
Why?
|
Paroxetine | 1 | 2004 | 26 | 0.250 |
Why?
|
Certification | 2 | 2004 | 58 | 0.250 |
Why?
|
Fluoxetine | 1 | 2004 | 42 | 0.240 |
Why?
|
Gatekeeping | 1 | 2003 | 3 | 0.240 |
Why?
|
Specialty Boards | 1 | 2004 | 24 | 0.240 |
Why?
|
Marketing | 1 | 2004 | 23 | 0.240 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2003 | 16 | 0.230 |
Why?
|
Truth Disclosure | 1 | 2004 | 87 | 0.230 |
Why?
|
Depressive Disorder | 1 | 2004 | 218 | 0.230 |
Why?
|
Information Dissemination | 1 | 2004 | 103 | 0.230 |
Why?
|
Comprehension | 1 | 2003 | 79 | 0.230 |
Why?
|
Neurology | 1 | 2004 | 69 | 0.230 |
Why?
|
Medicine | 1 | 2004 | 89 | 0.220 |
Why?
|
Mental Disorders | 2 | 2003 | 371 | 0.220 |
Why?
|
Research Design | 2 | 2003 | 594 | 0.210 |
Why?
|
Drug Prescriptions | 1 | 2003 | 141 | 0.210 |
Why?
|
Suicide | 1 | 2004 | 139 | 0.210 |
Why?
|
Bipolar Disorder | 1 | 2004 | 377 | 0.200 |
Why?
|
Ethics, Medical | 1 | 2004 | 306 | 0.200 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 1168 | 0.160 |
Why?
|
Humans | 19 | 2010 | 86281 | 0.150 |
Why?
|
Career Choice | 1 | 2010 | 139 | 0.080 |
Why?
|
Child | 3 | 2004 | 6913 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 450 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2006 | 185 | 0.070 |
Why?
|
Newspapers as Topic | 1 | 2004 | 6 | 0.060 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2004 | 28 | 0.060 |
Why?
|
Internship and Residency | 2 | 2004 | 1001 | 0.060 |
Why?
|
Ethics, Pharmacy | 1 | 2003 | 1 | 0.060 |
Why?
|
Cognitive Dissonance | 1 | 2003 | 3 | 0.060 |
Why?
|
Mental Health Services | 1 | 2003 | 48 | 0.060 |
Why?
|
Bias | 1 | 2004 | 127 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2003 | 64 | 0.060 |
Why?
|
United States | 3 | 2004 | 6637 | 0.060 |
Why?
|
Professional Competence | 1 | 2003 | 68 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2003 | 107 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2003 | 160 | 0.050 |
Why?
|
Risk | 1 | 2003 | 673 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2003 | 429 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2003 | 351 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2003 | 850 | 0.040 |
Why?
|
Communication | 1 | 2003 | 438 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2003 | 388 | 0.040 |
Why?
|
Practice Patterns, Physicians' | 1 | 2003 | 578 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2003 | 610 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 1030 | 0.040 |
Why?
|
Surveys and Questionnaires | 1 | 2003 | 2495 | 0.030 |
Why?
|
Time Factors | 1 | 2003 | 5198 | 0.030 |
Why?
|
Adolescent | 1 | 2004 | 8968 | 0.030 |
Why?
|
Adult | 1 | 2003 | 25577 | 0.020 |
Why?
|
Canada | 1 | 2003 | 204 | 0.010 |
Why?
|
Female | 1 | 2003 | 44405 | 0.010 |
Why?
|